[Toxic bodies: perceived risk of internal contamination by chemical compounds in Spain].

This article analyses the social perception of human exposure to chemical compounds and discourses and practices regarding bodily boundaries when faced with internal contamination. Based on qualitative and interdisciplinary research carried out in Catalonia, the social meanings attributed to the environmental and food dangers and risks related to chemical compounds that affect human health, and the place that the body takes in the production of these discourses, were explored. In order to do so, between June and November 2011, 43 semi-structured interviews with workers with some awareness of chemical contaminants were carried out, emphasizing how these people (re)interpret the different existing discourses about internal contamination as well as their perceptions regarding the introduction of chemical compounds into the body and the dangers that these substances pose to health.

Discourses on the Toxic Effects of Internal Chemical Contamination in Catalonia, Spain.

Human exposure to and contamination by environmental toxic compounds generates discourses and practices that merit greater attention. In this article, we assess internal chemical contamination and the risk of toxic effects as an experience related to the production of meaning in everyday life. Drawing on the analysis of semantic networks of narratives from semi-structured interviews conducted with 43 informants in Catalonia, Spain, we consider participants' perceptions of the health risks of toxic compounds, including social discourses on exposure, toxicity, and internal chemical contamination, and on responsibilities, consequences, and proposed strategies for controlling toxic compounds.

Long-term safety and efficacy of nevirapine-based approaches in HIV type 1-infected patients.

Using a multicenter, cross-sectional, observation study, the long-term safety, metabolic profile, and viral efficacy of nevirapine (NVP)-based approaches in HIV-1-infected patients treated for at least 2 years were assessed. For 4 months, all consecutive HIV-1-infected patients who had been receiving an NVP-containing regimen for at least 2 years were recruited. A total of 613 patients were included with a median follow-up period of 43 months (IQR: 31-51).